DelveInsight's report on Postoperative Pain Market Insights, Epidemiology, and Market Forecast-2034 covers historical and forecasted epidemiology, market trends, current treatment practices, emerging drugs, market size, and key companies in the US, EU5, and Japan. The market size in the US was ~USD 1,800 million in 2023, expected to increase by 2034. Key companies include Taiwan Liposome Company (TLC), Teikoku Pharma, Novartis, and others. Emerging therapies include TLC590, TPU-006, Libvatrep, and more.